Skip to Content

Blog

Category: General

A New Era in DLBCL Treatment

Published on Feb 12, 2025

Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin’s lymphoma (NHL), accounting for 30-40% of cases globally. While treatments like chemotherapy, including the R-CHOP regimen, can lead to remission in many patients, relapsed or refractory cases remain challenging, with limited long-term options. CAR T cell therapy transforms the treatment of DLBCL, providing renewed hope to patients by harnessing the body’s immune system to eliminate cancerous cells. …

Overcoming B-ALL With Enhanced CAR T Manufacturing

Published on Feb 10, 2025

B cell acute lymphoblastic leukemia (B-ALL) is an aggressive cancer affecting the bone marrow and blood. When traditional treatments like chemotherapy and radiation fall short in relapsed or refractory cases, CAR T cell therapy provides a transformative new option, offering hope via T cells engineered to target and destroy cancerous B cells. At Akadeum Life Sciences, our innovative cell isolation technologies, including the AlerionTM Microbubble Cell Separation System and our …

From Beads to Microbubbles: T Cell Isolation

Published on Jan 24, 2025

Whether for basic science or advanced applications like CAR T therapy, the efficiency and precision of cell isolation techniques can make or break research outcomes and therapeutic timelines. While magnetic beads have long served as the backbone of T cell isolation, their scalability, speed, and cell health preservation limitations are becoming increasingly apparent. Akadeum Life Sciences’ Alerion™ Microbubble Cell Separation System addresses these challenges with innovative, scalable solutions that integrate …

Negative Selection at Scale: Driving the Next Era of CAR T Immunotherapy Manufacturing

Published on Jan 10, 2025

Rising cancer rates have been featured heavily in the news this year, especially among younger adults. As cancer rates continue to climb, the need for innovative treatments has never been more pressing. Over recent years, immunotherapy, particularly CAR T cell therapy, emerged as a promising approach, offering renewed hope to patients facing challenging diagnoses through a personalized approach.  However, the increasing demand for these therapies revealed significant bottlenecks in the …

Precision Gene Editing for CAR T Cell Therapy

Updated on Feb 17, 2025

Unlocking the Power of Precision Gene Editing for CAR T Cell Therapy Precision is paramount in CAR T cell therapy. As a lab-based cancer treatment technique, CAR T therapy hinges on scientists’ ability to genetically engineer T cells to express receptors that target cancer cells.  T cell populations must be viable and robust enough to undergo gene editing effectively. Therefore, high-quality cell isolation is essential to ensuring CAR T cell …

Boost T Cell Recovery with Cell Depletion Kits

Updated on Dec 10, 2024

The Role of T Cell Depletion in Optimizing T Cell Recovery As CAR T cell therapies continue to transform cancer treatment, one critical challenge is maximizing the purity and functionality of CAR T cell cultures. T cells are engineered to target and destroy cancer cells in these therapies, making them a powerful option for cancers like leukemia and lymphoma.  However, an essential step in processing CAR T cells in allogeneic …

Scaling Antigen-Specific Immune Response Research

Updated on Dec 3, 2024

When researchers unlock the secrets of T cells, their discoveries often pave the way for groundbreaking advancements in immunotherapy. Antigen-specific T cells, in particular, recognize and neutralize specific threats like pathogens and cancer cells. Their role in targeted immune responses makes them essential in modern immunotherapy and vaccine development. If antigen-specific T cells are crucial for therapies, effectively isolating them may be the key to their success. Emerging Research Applications …

Boosting T Cell Health and Viability With Better Separation

Updated on Dec 10, 2024

Maintaining the health and viability of immune cells in CAR T cell therapy and adoptive cell transfer is critical. These cells must endure isolation and expansion processes without losing their functionality. Even slight inefficiencies can compromise cell integrity and cell health, resulting in diminished therapeutic outcomes. Akadeum’s Alerion™ Microbubble Cell Separation System solves these challenges by offering a gentle, scalable method for T cell separation, ensuring better health and viability. …

Cell Dissociation Methods for Disaggregation of Tissue: Mechanical vs Enzymatic vs Chemical

Updated on Nov 21, 2024

Cell dissociation is the process of breaking down tissue or cell culture into individual cells, a critical step in preparing samples for research and therapeutic applications. Different methods of cell dissociation, including enzymatic, mechanical, and chemical techniques, are used to ensure the viability and functionality of cells for further study. Read on to explore the different methods and their importance in advancing scientific research. Cell Dissociation Methods Research is undertaken …

The Importance of Isolating Antigen-Specific T Cells

Updated on Dec 9, 2024

Antigen-specific T cells offer crucial insights into the body’s immune response to diseases. These specialized cells, which recognize and respond to specific antigens, are essential for: Developing effective vaccines Understanding infectious diseases Advancing cancer immunotherapies In this way, isolating T cells precisely and efficiently is vital for accelerating research and improving therapeutic outcomes. What Are Antigen-Specific T Cells? Antigen-specific T cells are a subset of T cells that recognize and …

Back to Top